National Institutes of Health Director Jay Bhattacharya launched a new bi-monthly “Scientific Freedom Lecture” series with a ...
Four years after infection with the wild-type SARS-CoV-2 strain, up to 60% of health care workers (HCWs) in Switzerland still ...
The group’s core expertise lies in translational research on emerging viruses with direct real-world impact, including the acceleration of diagnostic solutions, the provision of evidence for public ...
The COVID-19 pandemic's early death toll was much higher than the official U.S. count, according to a new study that spotlights dramatic disparities in ...
According to WHO, approximately 6% of the worldwide population who contract Covid-19 – some 400 million people – go on to develop a long-lasting form of the disease. These figures demonstrate that the ...
A study published Wednesday shows that the early U.S. death toll during the COVID-19 pandemic was higher than previously recorded. The journal Science Advances found that more than 155,000 ...
North Korea has qualified for the Women’s World Cup again after a long absence following a doping scandal in 2011. North ...
The question of origins has long bedevilled the study of pandemics. In pre-modern times, outbreaks of infectious disease were ...
Hannah Murphy. When the University of Minnesota Crookston welcomed new faculty members to campus in August 2025, Hannah Murphy, assistant professor in biology, arrived ready to cr ...
Receiving the COVID-19 vaccine and booster reduces preeclampsia risk by nearly 60% among pregnant patients with preexisting morbidities.
RNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production. Scientists are now testing a new platform called DoriVac, which uses folded DNA ...
A 4th dose of the bivalent or monovalent Omicron BA.1-adapted BNT162b2 vaccine elicits robust neutralizing responses in adults aged 18 to 55.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results